BAYER RAPIDPOINT 400 SYSTEM

Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

BAYER CORP.

The following data is part of a premarket notification filed by Bayer Corp. with the FDA for Bayer Rapidpoint 400 System.

Pre-market Notification Details

Device IDK002738
510k NumberK002738
Device Name:BAYER RAPIDPOINT 400 SYSTEM
ClassificationElectrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Applicant BAYER CORP. 63 NORTH ST. Medfield,  MA  02052 -1688
ContactWilliam J Pignato
CorrespondentWilliam J Pignato
BAYER CORP. 63 NORTH ST. Medfield,  MA  02052 -1688
Product CodeCHL  
Subsequent Product CodeCEM
Subsequent Product CodeCGA
Subsequent Product CodeCGZ
Subsequent Product CodeGKF
Subsequent Product CodeJFP
Subsequent Product CodeJGS
CFR Regulation Number862.1120 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2000-09-01
Decision Date2000-12-19

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414515250 K002738 000
00630414482163 K002738 000
00630414469225 K002738 000
00630414465883 K002738 000
00630414444581 K002738 000
00630414443492 K002738 000
00630414443485 K002738 000
00630414016627 K002738 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.